INO

#3974
Inovio Pharmaceuticals, Inc. - Common Stock
1.3 3 USD
+1.53%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.31
1.33
년간 변동
1.03
2.98
일일 변동
+1.53%
월간 변동
+17.70%
6달 변화
-35.44%
년간 변동율
-37.26%
이전 종가
1.3 1
Open
1.3 2
저가
1.3 1
High
1.3 3
양
150
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 109.42 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-0.96
주가매출액비율
1 248.52

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

뉴스